Diagnostic Confidence for CLN3 Disease (Juvenile Batten Disease)

被引：0
|
作者：
Masten, Margaux C. [1 ]
Vierhile, Amy [1 ]
Vermilion, Jennifer [1 ]
Adams, Heather R. [1 ]
Zimmerman, Grace A. [1 ]
Corre, Camille [1 ]
Augustine, Erika F. [1 ]
Mink, Jonathan W. [1 ]
机构：
[1] Univ Rochester, Med Ctr, Rochester, NY 14627 USA
来源：
NEUROLOGY | 2021年 / 96卷 / 15期
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
1863
引用
收藏
页数：3
相关论文
共 50 条
  • [41] Therapeutic efficacy of antisense oligonucleotides in mouse models of CLN3 Batten disease
    Centa, Jessica L.
    Jodelka, Francine M.
    Hinrich, Anthony J.
    Johnson, Tyler B.
    Ochaba, Joseph
    Jackson, Michaela
    Duelli, Dominik M.
    Weimer, Jill M.
    Rigo, Frank
    Hastings, Michelle L.
    NATURE MEDICINE, 2020, 26 (09) : 1444 - 1451
  • [42] Defective intracellular transport of CLN3 is the molecular basis of Batten disease (JNCL)
    Järvelä, I
    Lehtovirta, M
    Tikkanen, R
    Kyttälä, A
    Jalanko, A
    HUMAN MOLECULAR GENETICS, 1999, 8 (06) : 1091 - 1098
  • [43] Therapeutic efficacy of antisense oligonucleotides in mouse models of CLN3 Batten disease
    Jessica L. Centa
    Francine M. Jodelka
    Anthony J. Hinrich
    Tyler B. Johnson
    Joseph Ochaba
    Michaela Jackson
    Dominik M. Duelli
    Jill M. Weimer
    Frank Rigo
    Michelle L. Hastings
    Nature Medicine, 2020, 26 : 1444 - 1451
  • [44] Genomic structure and complete nucleotide sequence of the Batten disease gene, CLN3
    Mitchison, HM
    Munroe, PB
    ORawe, AM
    Taschner, PEM
    DeVos, N
    Kremmidiotis, G
    Lensink, I
    Munk, AC
    DArigo, KL
    Anderson, JW
    Lerner, TJ
    Moyzis, RK
    Callen, DF
    Breuning, MH
    Doggett, NA
    Gardiner, RM
    Mole, SE
    GENOMICS, 1997, 40 (02) : 346 - 350
  • [45] Splice-Switching Antisense Oligonucleotides for the Treatment of CLN3 Batten Disease
    Centa, Jessica L.
    Jodelka, Francine M.
    Hinrich, Anthony J.
    Johnson, Tyler B.
    Rigo, Frank
    Weimer, Jill M.
    Hastings, Michelle L.
    MOLECULAR THERAPY, 2019, 27 (04) : 303 - 303
  • [46] Targeted disruption of the Cln3 gene provides a mouse model for Batten disease
    Mitchison, HM
    Bernard, DJ
    Greene, NDE
    Cooper, JD
    Junaid, MA
    Pullarkat, RK
    de Vos, N
    Breuning, MH
    Owens, JW
    Mobley, WC
    Gardiner, RM
    Lake, BD
    Taschner, PEM
    Nussbaum, RL
    NEUROBIOLOGY OF DISEASE, 1999, 6 (05) : 321 - 334
  • [47] Retinal pathology and function in a Cln3 knockout mouse model of juvenile neuronal ceroid lipofuscinosis (Batten disease)
    Seigel, GM
    Lotery, A
    Kummer, A
    Bernard, DJ
    Greene, NDE
    Turmaine, M
    Derksen, T
    Nussbaum, RL
    Davidson, B
    Wagner, J
    Mitchison, HM
    MOLECULAR AND CELLULAR NEUROSCIENCE, 2002, 19 (04) : 515 - 527
  • [48] Isolation and chromosomal mapping of a mouse homolog of the Batten disease gene CLN3
    Lee, RL
    Johnson, KR
    Lerner, TJ
    GENOMICS, 1996, 35 (03) : 617 - 619
  • [49] A novel porcine model of CLN3 Batten disease recapitulates clinical phenotypes
    Swier, Vicki J.
    White, Katherine A.
    Johnson, Tyler B.
    Wang, Xiaojun
    Han, Jimin
    Pearce, David A.
    Singh, Ruchira
    Drack, Arlene V.
    Pfeifer, Wanda
    Rogers, Christopher S.
    Brudvig, Jon J.
    Weimer, Jill M.
    DISEASE MODELS & MECHANISMS, 2023, 16 (08)
  • [50] Speech, Language and Non-verbal Communication in CLN2 and CLN3 Batten Disease
    Morison, Lottie D.
    Whiteman, Ineka T.
    Vogel, Adam P.
    Tilbrook, Lisa
    Fahey, Michael C.
    Braden, Ruth
    Bredebusch, Joanna
    Hildebrand, Michael S.
    Scheffer, Ingrid E.
    Morgan, Angela T.
    JOURNAL OF INHERITED METABOLIC DISEASE, 2025, 48 (01)
12345